GEVOGevo, Inc.
$1.36-38% 1Y
$1.36
$1.2752 weeks$2.78
GEVO as reported
Gevo, Inc. reported $178M of revenue over the trailing twelve months, +121% on the year before. 10 reported series are charted on this page, each one as filed.
$178M
Revenue, trailing twelve months · to Q2 2026 · +121% against the twelve months before
- Net income
- −$213M
Net income · +265% year on year · trailing twelve months to Q2 2026
- Free cash flow
- −$57M
Free cash flow · −38% year on year · trailing twelve months to Q2 2026
- Operating margin
- −99%
Operating margin · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $178M | +121% | Q2 2026 |
| Net income | −$213M | +265% | Q2 2026 |
| EPS | −$0.89 | +242% | Q2 2026 |
| Gross margin | 47% | n/a | Q2 2026 |
| Operating margin | −99% | n/a | Q2 2026 |
| Net margin | −116% | n/a | Q2 2026 |
| ROE | −26% | n/a | Q2 2026 |
| ROA | −15% | n/a | Q2 2026 |
| ROIC | −12% | n/a | Q2 2026 |
| Free cash flow | −$57M | −38% | Q2 2026 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Gevo, Inc. (GEVO) · Revenue and profitRevenue and profitGevo, Inc. (GEVO)
RevenueNet incomeTrailing twelve months
Powered byryufin.com
Specialty Chemicals
Ranks #33 of 33 by RyuScore